We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.79T
| $2.68B | 5.72% |
15,638,063
-452,088
| -3% | -$82.9M |
|
2
Microsoft
MSFT
$2.9T
| $2.51B | 5.35% |
7,935,302
-56,803
| -0.7% | -$18.8M |
|
3
Alphabet (Google) Class A
GOOGL
$4.17T
| $1.33B | 2.84% |
10,163,273
-147,537
| -1% | -$19.1M |
|
4
NVIDIA
NVDA
$5.14T
| $1.22B | 2.6% |
27,997,860
-199,060
| -0.7% | -$8.92M |
|
5
Amazon
AMZN
$2.63T
| $1.22B | 2.59% |
9,560,478
-23,178
| -0.2% | -$3.11M |
|
6
UnitedHealth
UNH
$392B
| $1.02B | 2.19% |
2,030,580
-14,682
| -0.7% | -$7.23M |
|
7
Meta Platforms (Facebook)
META
$1.59T
| $1.01B | 2.16% |
3,365,918
-17,008
| -0.5% | -$5.12M |
|
8
Mastercard
MA
$470B
| $779M | 1.66% |
1,966,514
-26,379
| -1% | -$10.6M |
|
|
9
ExxonMobil
XOM
$640B
| $736M | 1.57% |
6,256,315
-798,503
| -11% | -$87.6M |
|
10
Tesla
TSLA
$1.4T
| $672M | 1.44% |
2,687,146
+153,477
| +6% | +$39.4M |
|
11
Walmart Inc
WMT
$870B
| $628M | 1.34% |
11,781,960
-290,700
| -2% | -$15.5M |
|
12
JPMorgan Chase
JPM
$926B
| $609M | 1.3% |
4,201,632
-378,063
| -8% | -$56.7M |
|
13
Merck
MRK
$315B
| $556M | 1.19% |
5,398,486
+122,990
| +2% | +$13.3M |
|
14
Berkshire Hathaway Class B
BRK.B
$1.06T
| $506M | 1.08% |
1,443,461
-55,801
| -4% | -$19.8M |
|
|
15
Johnson & Johnson
JNJ
$615B
| $481M | 1.03% |
3,090,682
-892,062
| -22% | -$147M |
|
16
Chevron
CVX
$384B
| $440M | 0.94% |
2,608,840
+348,161
| +15% | +$56.2M |
|
17
Thermo Fisher Scientific
TMO
$196B
| $432M | 0.92% |
853,752
+62,973
| +8% | +$33.6M |
|
|
18
Alphabet (Google) Class C
GOOG
$4.17T
| $419M | 0.89% |
3,179,169
-122,564
| -4% | -$15.9M |
|
19
ConocoPhillips
COP
$145B
| $410M | 0.87% |
3,419,043
-100,531
| -3% | -$11.7M |
|
20
Home Depot
HD
$330B
| $408M | 0.87% |
1,350,383
+35,145
| +3% | +$11.3M |
|
21
Procter & Gamble
PG
$347B
| $402M | 0.86% |
2,752,877
-127,750
| -4% | -$19.5M |
|
22
Abbott
ABT
$175B
| $393M | 0.84% |
4,055,123
-175,422
| -4% | -$18.4M |
|
23
TJX Companies
TJX
$172B
| $379M | 0.81% |
4,268,785
-134,652
| -3% | -$11.9M |
|
24
CME Group
CME
$90.1B
| $363M | 0.78% |
1,814,541
+29,143
| +2% | +$5.79M |
|
25
Broadcom
AVGO
$1.89T
| $351M | 0.75% |
4,220,040
+199,560
| +5% | +$17.3M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.